Tess Clément

Associate

Amsterdam + 31.20.305.4250

Connect:

Tess Clément richt zich in haar praktijk op binnenlandse en grensoverschrijdende mergers & acquisitions. Tess heeft ervaring met het adviseren over een breed scala aan private equity-transacties, venture capital-transacties, joint ventures en algemene ondernemingsrecht- en transactiekwesties.

Tess adviseert regelmatig over technologiegerelateerde mergers & acquisitions en transacties in de productie-, chemische, life sciences- en consumptiegoederenindustrie.

Recente belangrijke transacties bij Jones Day zijn onder meer het adviseren van: Eurobio Scientific SA bij het succesvolle bod op GenDX; The Timken Company bij de overname van Lagersmit; SmartSD bij het strategische partnerschap met Cobepa; Smile Invest bij de verkoop van Rovers Medical Devices; Monolithic Power Systems bij de overname van Axign, een in Nederland gevestigde fabless halfgeleiderstartup; Partech Partners bij de strategische investering in Payt, een toonaangevend SaaS-platform voor debiteurenbeheer; en Gimv N.V. bij de verkoop van United Dutch Breweries.

Voordat Tess in 2021 bij Jones Day in dienst trad, liep ze stage bij verschillende Nederlandse en internationale advocatenkantoren.

Experience

  • Gimv invests in AlpineJones Day advised Gimv in the acquisition of a majority stake in Alpine, one of the leading international consumer brands providing passive hearing protection solutions, from Vendis Capital, the founders and management team.
  • Fortino participates in growth investment in CenoscoJones Day advised existing investor Fortino Capital Partners on its participation in the growth investment in Cenosco B.V., a leading provider of asset integrity management software, led by Summit Partners.
  • Gimv sells United Dutch BreweriesJones Day advised Gimv N.V. in the sale of United Dutch Breweries (UDB) to Brouwerij Martens.
  • Joint Administrators of The Body Shop International Limited (in administration) sell business and assetsJones Day advised Geoffrey Rowley, Anthony Wright and Alastair Massey of FRP Advisory in their capacity as joint administrators of The Body Shop International Limited (in administration), an appointee of the shareholder, Aurelius Investment Advisory Limited, in connection with the trading administration and subsequent sale of the company's business and assets.
  • IBS Capital announces the acquisition of its shares by BlackFin Capital PartnersJones Day is advising the shareholders of IBS Capital Management B.V. in the controlled auction sale of IBS to BlackFin Capital Partners.
  • Partech invests in PaytJones Day advised Partech Partners in the €55 million strategic investment in Payt, a leading accounts receivable SaaS platform.
  • Smile Invest sells Rovers Medical DevicesJones Day advised Smile Invest in the sale of Rovers Medical Devices B.V., the leading designer and manufacturer of sample collection devices used in the prevention and diagnostics of cervical cancer, to Halma plc, a global group of life-saving technology companies.
  • Monolithic Power Systems acquires Axign B.V.Jones Day represented Monolithic Power Systems, Inc., a leading company in high-performance power solutions, in the acquisition of Axign B.V., a Netherlands-based fabless semiconductor startup that specializes in programmable multicore DSP (digital signal processors) that demonstrate near-zero distortion signals with significantly reduced power consumption for automotive and consumer audio systems.
  • SmartSD enters into strategic partnership with CobepaJones Day advised SmartSD and its longstanding stakeholders Smile Invest, co-founders and management on a strategic partnership with new majority shareholder Cobepa, a leading European private equity company.
  • GfK sells European Consumer Panel (GfK CP) business to YouGovJones Day advised GfK SE in the €315 million sale of its European Consumer Panel business (GfK CP) to YouGov PLC, a leading international online research data and analytics technology group headquartered in the United Kingdom and listed on the London Stock Exchange (LSE: YOU).
  • AURELIUS acquires The Body ShopJones Day advised private equity investor AURELIUS on its acquisition of The Body Shop from Natura & Co S.A.
  • Timken acquires LagersmitJones Day advised The Timken Company in the acquisition of Lagersmit, a Netherlands-based manufacturer of highly engineered sealing solutions for demanding marine, dredging, water, tidal energy and other industrial applications.
  • Riverside sells Guestline to Access GroupJones Day represented The Riverside Company in connection with the sale of portfolio company Guestline, a UK-based provider of mission critical software for the hospitality sector, to Access Group.
  • FLEETCOR acquires Global Reach GroupJones Day advised FLEETCOR Technologies, Inc. in the acquisition of Global Reach Group, a UK-based cross-border payments provider.
  • Eurobio Scientific acquires GenDxJones Day advised Eurobio Scientific SA in the acquisition and financing of the Dutch company Genome Diagnostics BV (GenDx) from its founder and its shareholders for €135 million (net of adjusted cash).
  • Avient acquires DSM Protective Materials businessJones Day advised Avient Corporation (NYSE: AVNT), a leading provider of specialized and sustainable material solutions, in the $1.485 billion acquisition and financing of Koninklijke DSM N.V.’s protective materials business, a leading specialty engineered materials business built around the invention of Dyneema®, the world’s strongest fiber.
  • Aurelius sells remaining Office Depot Europe business to strategic buyer RAJA GroupJones Day advised AURELIUS Equity Opportunities in the sale of Office Depot Europe, which includes the remaining Viking and Office Depot Europe activities to strategic buyer RAJA Group.
    •

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.